DD248588A5 - Verfahren zur herstellung von hydroxy-und alkoxypyrimidinen - Google Patents
Verfahren zur herstellung von hydroxy-und alkoxypyrimidinen Download PDFInfo
- Publication number
- DD248588A5 DD248588A5 DD86292804A DD29280486A DD248588A5 DD 248588 A5 DD248588 A5 DD 248588A5 DD 86292804 A DD86292804 A DD 86292804A DD 29280486 A DD29280486 A DD 29280486A DD 248588 A5 DD248588 A5 DD 248588A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- phenyl
- alkyl
- substituted
- hydrogen
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/758,199 US4711888A (en) | 1985-07-24 | 1985-07-24 | Hydroxy and alkoxy pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD248588A5 true DD248588A5 (de) | 1987-08-12 |
Family
ID=25050889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86292804A DD248588A5 (de) | 1985-07-24 | 1986-07-23 | Verfahren zur herstellung von hydroxy-und alkoxypyrimidinen |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4711888A (fi) |
| EP (1) | EP0210044B1 (fi) |
| JP (1) | JPH0647579B2 (fi) |
| KR (1) | KR890001549B1 (fi) |
| CN (1) | CN1006792B (fi) |
| AU (1) | AU569194B2 (fi) |
| CA (1) | CA1265519A (fi) |
| DD (1) | DD248588A5 (fi) |
| DE (1) | DE3673718D1 (fi) |
| DK (1) | DK162986C (fi) |
| EG (1) | EG18181A (fi) |
| ES (1) | ES2000734A6 (fi) |
| FI (1) | FI89911C (fi) |
| GR (1) | GR861917B (fi) |
| HU (1) | HU196764B (fi) |
| IE (1) | IE63404B1 (fi) |
| IL (1) | IL79471A0 (fi) |
| NO (1) | NO173442C (fi) |
| NZ (1) | NZ216951A (fi) |
| PH (1) | PH22484A (fi) |
| PL (2) | PL150617B1 (fi) |
| PT (1) | PT83036B (fi) |
| SU (1) | SU1574171A3 (fi) |
| YU (1) | YU45020B (fi) |
| ZA (1) | ZA865489B (fi) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
| US4959365A (en) * | 1986-10-31 | 1990-09-25 | Pfizer Inc. | Topical compositions of lipophilic pharmaceuticals agents |
| HU199683B (en) * | 1987-07-22 | 1990-03-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity |
| HU206203B (en) * | 1987-12-02 | 1992-09-28 | Pfizer | Process for producing acyl derivatives of hydroxypyrimidines |
| US5071852A (en) * | 1988-12-14 | 1991-12-10 | Pfizer Inc. | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production |
| ATE96321T1 (de) * | 1988-12-14 | 1993-11-15 | Pfizer | Derivate von 5-hydroxy- und 5-methoxy-2-aminopyrimidin als inhibitoren der interleukin-1produktion. |
| US4940712A (en) * | 1989-05-26 | 1990-07-10 | Pfizer Inc. | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| CA2099868C (en) * | 1991-01-31 | 2002-04-02 | Thomas Richard Belliotti | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
| US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| EP0902019A4 (en) * | 1996-05-16 | 2002-03-27 | Nissan Chemical Ind Ltd | METHOD FOR PRODUCING PYRIMIDINE COMPOUNDS |
| US5958934A (en) * | 1996-05-23 | 1999-09-28 | Syntex (U.S.A.) Inc. | Aryl pyrimidine derivatives and uses thereof |
| US5952331A (en) * | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
| TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
| US6489344B1 (en) | 1998-06-19 | 2002-12-03 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| WO2002000683A2 (en) * | 2000-06-23 | 2002-01-03 | Vanderbilt University | Novel chain-breaking antioxidants |
| DE102004054080A1 (de) * | 2004-11-09 | 2006-05-11 | Wella Ag | Haut- oder Haarbehandlungsmittel mit Schutzeffekt |
| US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| JP2008156048A (ja) * | 2006-12-22 | 2008-07-10 | Isamu Nakamura | 車両用板材キャリア |
| US8877766B2 (en) | 2013-02-15 | 2014-11-04 | Peter F. Kador | Neuroprotective multifunctional antioxidants and their monofunctional analogs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN153791B (fi) | 1979-03-10 | 1984-08-18 | Soc D Etudes Prod Chimique | |
| US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
| US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
| EP0164204A1 (en) * | 1984-05-12 | 1985-12-11 | FISONS plc | Novel pharmaceutically useful pyrimidines |
-
1985
- 1985-07-24 US US06/758,199 patent/US4711888A/en not_active Expired - Lifetime
-
1986
- 1986-07-16 DE DE8686305466T patent/DE3673718D1/de not_active Expired - Fee Related
- 1986-07-16 EP EP86305466A patent/EP0210044B1/en not_active Expired - Lifetime
- 1986-07-21 IL IL79471A patent/IL79471A0/xx not_active IP Right Cessation
- 1986-07-22 PT PT83036A patent/PT83036B/pt not_active IP Right Cessation
- 1986-07-22 CA CA000514336A patent/CA1265519A/en not_active Expired - Fee Related
- 1986-07-22 GR GR861917A patent/GR861917B/el unknown
- 1986-07-22 EG EG453/86A patent/EG18181A/xx active
- 1986-07-23 SU SU864027808A patent/SU1574171A3/ru active
- 1986-07-23 HU HU863000A patent/HU196764B/hu not_active IP Right Cessation
- 1986-07-23 DD DD86292804A patent/DD248588A5/de not_active IP Right Cessation
- 1986-07-23 CN CN86104539A patent/CN1006792B/zh not_active Expired
- 1986-07-23 KR KR1019860005974A patent/KR890001549B1/ko not_active IP Right Cessation
- 1986-07-23 NZ NZ216951A patent/NZ216951A/xx unknown
- 1986-07-23 DK DK349486A patent/DK162986C/da active
- 1986-07-23 AU AU60447/86A patent/AU569194B2/en not_active Ceased
- 1986-07-23 NO NO862956A patent/NO173442C/no unknown
- 1986-07-23 FI FI863029A patent/FI89911C/fi not_active IP Right Cessation
- 1986-07-23 ZA ZA865489A patent/ZA865489B/xx unknown
- 1986-07-23 ES ES8600529A patent/ES2000734A6/es not_active Expired
- 1986-07-23 PH PH34054A patent/PH22484A/en unknown
- 1986-07-23 YU YU1321/86A patent/YU45020B/xx unknown
- 1986-07-23 IE IE195286A patent/IE63404B1/en not_active IP Right Cessation
- 1986-07-24 JP JP61174704A patent/JPH0647579B2/ja not_active Expired - Lifetime
- 1986-07-24 PL PL1986260784A patent/PL150617B1/pl unknown
- 1986-07-24 PL PL1986271856A patent/PL151571B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD248588A5 (de) | Verfahren zur herstellung von hydroxy-und alkoxypyrimidinen | |
| DE2705446C2 (fi) | ||
| DE3033157A1 (de) | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel | |
| DD201790A5 (de) | Verfahren zur herstellung von 3-aryl-5-isothiazolen | |
| NO170883B (no) | Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater | |
| DE3129309A1 (de) | Hypoglykaemische 5-substituierte oxazolidin-2,4-dione | |
| DE3530046C2 (de) | Äthylendiaminmonoamid-Derivate | |
| DE10133665A1 (de) | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung | |
| DE1965264A1 (de) | Pyrazinoylsulfamide und Verfahren zu ihrer Herstellung | |
| DD253823A5 (de) | Verfahren zur herstellung neuartiger thienopyridone | |
| EP0122580A1 (de) | Pyrimidinderivate, deren Herstellung und pharmazeutische Präparate | |
| EP0171739B1 (en) | Imidazo[1,5-a]pyrimidine derivatives and process for their preparation | |
| US4940712A (en) | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors | |
| EP0093252B1 (de) | Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2443682C2 (de) | Neue 2,4-Diamino-5-benzylpyrimidine | |
| EP0171645A1 (de) | Neue 2H-1-Benzopyran-2-on-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten | |
| EP0319170B1 (en) | Acyl derivatives of hydroxy pyrimidines | |
| DE2509037A1 (de) | 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| IE41563B1 (en) | Sulfonamides | |
| EP0124630A1 (de) | Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel | |
| DE2656227C2 (de) | Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE2354145A1 (de) | Chinazolin-2(lh)-one und verfahren zu ihrer herstellung | |
| DE3121137A1 (de) | Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung" | |
| DE2414612A1 (de) | 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
| EP0006987A1 (en) | 2,4-Diamino-5-benzylpyrimidines, especially for the treatment of microbial infections, pharmaceutical compositions containing these compounds and processes for preparing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NPV | Change in the person, the name or the address of the representative (addendum to changes before extension act) | ||
| ENJ | Ceased due to non-payment of renewal fee |